Schémas de prescription alternatif du sunitinib dans le cancer du rein métastatique: de l'underground au grand public?

The alternating schedule of sunitinib 2/3 (50 mg/day) may be a better alternative to schedule 4/6in terms of tolerance. If toxicity occurs with 50 mg/day on a schedule 4/6, it would probably offer a better alternative in terms of efficiency than dose reduction. The results of ongoing and future studies are expected to prospectively validate the concept.